◆英語タイトル:Les Laboratoires Servier SAS - Strategic SWOT Analysis Review
◆商品コード:DATA904C3382
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Les Laboratoires Servier SAS – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company’s portfolio of marketed products treat central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women’s and male health issues, gastrointestinal diseases, hematological disorders, hormonal disorders and others. It invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs) worldwide. The company also provides generic drugs and contract development and manufacturing services across its global network. Servier sells its products in Europe, North America, South America, Middle East, Africa and Asia. Servier headquartered in Suresnes, France.
Les Laboratoires Servier SAS Key Recent Developments
Jul 04,2018: Servier Netherlands mobilizes for Stem Cell Donation
Jun 06,2018: Servier Announces Launch of Servier BioInnovation in the U.S.
Apr 12,2018: WeHealth by Servier and UCSF form partnership to identify most promosing e-health startups
Apr 03,2018: Servier And Scandicure Enter Into Agreement To Conduct Research In Field Of Metabolic Diseases
Mar 13,2018: WeHealth by Servier and DEEPLINK MEDICAL sign a partnership to develop a new e-health solution
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Les Laboratoires Servier SAS – Key Facts 6
Les Laboratoires Servier SAS – Key Employees 7
Les Laboratoires Servier SAS – Major Products and Services 8
Les Laboratoires Servier SAS – History 10
Les Laboratoires Servier SAS – Company Statement 16
Les Laboratoires Servier SAS – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 20
Company Overview 20
Les Laboratoires Servier SAS – Business Description 21
Product Category: Branded 21
Overview 21
Performance 21
Product Category: Generics 21
Overview 21
Performance 22
Geographical Segment: Africa and Middle East 22
Performance 22
Geographical Segment: Asia and Oceania 22
Performance 22
Geographical Segment: Europe (Excluding France) 22
Performance 22
Geographical Segment: France 22
Performance 22
Geographical Segment: Other European countries (non-EU) 22
Performance 22
Geographical Segment: The Americas 22
Performance 22
R&D Overview 22
Les Laboratoires Servier SAS – Corporate Strategy 24
Les Laboratoires Servier SAS – SWOT Analysis 25
SWOT Analysis – Overview 25
Les Laboratoires Servier SAS – Strengths 25
Les Laboratoires Servier SAS – Weaknesses 26
Les Laboratoires Servier SAS – Opportunities 27
Les Laboratoires Servier SAS – Threats 28
Les Laboratoires Servier SAS – Key Competitors 29
Section 3 – Company’s Lifesciences Financial Deals and Alliances 30
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Les Laboratoires Servier SAS, Recent Deals Summary 32
Section 4 – Company’s Recent Developments 33
Jul 04, 2018: Servier Netherlands mobilizes for Stem Cell Donation 33
Jun 06, 2018: Servier Announces Launch of Servier BioInnovation in the U.S. 34
Apr 12, 2018: WeHealth by Servier and UCSF form partnership to identify most promosing e-health startups 35
Mar 13, 2018: WeHealth by Servier and DEEPLINK MEDICAL sign a partnership to develop a new e-health solution 36
Mar 06, 2018: Servier appoints a Chief Patient Officer 37
Dec 06, 2017: Vernalis and Servier Achieve Research Milestone in Third Oncology Collaboration 38
Dec 06, 2017: Vernalis and Servier Achieve Research Milestone 39
Oct 19, 2017: Servier CDMO expands Preparative Chromatography platform at Normandy Site to support market need 40
Jun 27, 2017: Servier is the first French pharmaceutical company to partner with Plug and Play Health & Wellness 41
Apr 26, 2017: Servier and Vernalis announce achievement of 3 milestones in their oncology drug discovery collaboration 42
Section 5 – Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Les Laboratoires Servier SAS, Key Facts 6
Les Laboratoires Servier SAS, Key Employees 7
Les Laboratoires Servier SAS, Major Products and Services 8
Les Laboratoires Servier SAS, History 10
Les Laboratoires Servier SAS, Subsidiaries 17
Les Laboratoires Servier SAS, Key Competitors 29
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Les Laboratoires Servier SAS, Recent Deals Summary 32
List of Figures
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31